ARQT icon

Arcutis Biotherapeutics
ARQT

Overview Fund Activity

143 hedge funds and large institutions have $797M invested in Arcutis Biotherapeutics in 2023 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 68 increasing their positions, 32 reducing their positions, and 20 closing their positions.

Holders
143
Holders Change
+2
Holders Change %
+1.42%
% of All Funds
2.29%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
22
Increased
68
Reduced
32
Closed
20
Calls
$3.99M
Puts
$1.13M
Net Calls
+$2.86M
Net Calls Change
-$8.25M

Top Buyers

1
Marshall Wace
1
Marshall Wace
United Kingdom
$25.4M
2
Bank of America
2
Bank of America
North Carolina
$17.8M
3
PCH
3
Polar Capital Holdings
United Kingdom
$34.5M
4
Holocene Advisors
4
Holocene Advisors
New York
$22.8M
5
MFS
5
Mirabella Financial Services
United Kingdom
$9.85M

Top Sellers

1
LGM
1
Logos Global Management
California
$0
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$0
3
Westfield Capital Management
3
Westfield Capital Management
Massachusetts
$0
4
Millennium Management
4
Millennium Management
New York
$0
5
CAM
5
Cormorant Asset Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
American Century Companies
26
American Century Companies
Missouri
$5.58M -$800K -72,870 -13%
OM
27
Opaleye Management
Massachusetts
$5.52M +$5.52M +502,000 New
Ensign Peak Advisors
28
Ensign Peak Advisors
Utah
$5.35M +$18.6K +1,688 +0.3%
Axa
29
Axa
France
$4.87M +$1.17M +106,693 +32%
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$4.82M +$744K +67,625 +18%
EC
31
EcoR1 Capital
California
$4.57M – – –
Northern Trust
32
Northern Trust
Illinois
$4.26M +$22.1K +2,009 +0.5%
Morgan Stanley
33
Morgan Stanley
New York
$3.71M +$1.54M +139,590 +70%
SAM
34
Sectoral Asset Management
Quebec, Canada
$3.49M +$1.25M +113,300 +56%
Rafferty Asset Management
35
Rafferty Asset Management
New York
$3.35M +$17.3K +1,577 +0.5%
Charles Schwab
36
Charles Schwab
California
$3.33M +$8.51K +774 +0.3%
SEI Investments
37
SEI Investments
Pennsylvania
$3.01M +$3.01M +273,599 New
Citadel Advisors
38
Citadel Advisors
Florida
$2.99M +$2.88M +261,888 +2,719%
MB
39
MPM BioImpact
Massachusetts
$2.8M -$87.3K -7,932 -3%
Goldman Sachs
40
Goldman Sachs
New York
$2.72M -$360K -32,689 -12%
Citigroup
41
Citigroup
New York
$2.68M +$1.22M +110,771 +83%
Parallax Volatility Advisers
42
Parallax Volatility Advisers
California
$2.49M +$1.79M +163,137 +258%
1CM
43
1492 Capital Management
Wisconsin
$2.46M +$539K +48,970 +28%
CC
44
Centiva Capital
New York
$2.2M +$2.2M +200,000 New
AA
45
AlphaCentric Advisors
Puerto Rico
$2.09M +$1.23M +111,500 +142%
Neuberger Berman Group
46
Neuberger Berman Group
New York
$2.01M +$183K +16,637 +10%
SVCM
47
Saturn V Capital Management
Texas
$1.96M -$3.4M -308,962 -63%
Prudential Financial
48
Prudential Financial
New Jersey
$1.79M +$726K +65,975 +68%
PP
49
PDT Partners
New York
$1.71M +$1.07M +97,607 +169%
TCM
50
Tekla Capital Management
Massachusetts
$1.64M – – –
1
2
3 4 5